Published on: 07/02/2024
Description
The U.S. Food and Drug Administration has approved an Alzheimer's drug that's been proven to slow memory and cognitive decline in patients with the disease.
The approval of Eli Lilly and Company's Kisunla on Tuesday comes after promising clinical trials showed the drug significantly slowed decline in multiple brain functions affected by Alzheimer's, including thinking and daily functioning. This is only the second time the FDA has approved a drug to treat Alzheimer's after clinical trials.
This is a developing story. Check back with Scripps News for updates.
Other Related News
07/04/2024
Fireworks on the Fourth of July are as old as the country itself And according to the Amer...
07/04/2024
Several types of dog food and cat food have been recalled due to listeria monocytogenes co...
07/04/2024
INDEPENDENT RECORD Nearly 1000 people attended the Capital City July 4th Celebration on ...
07/04/2024
Sidewalks were filled with people attending the Butte Fourth of July parade from the sta...
07/04/2024
The Food and Drug Administration revealed a death investigation potentially linked to prod...
Follow
Download Our App
Copyright 2023 © Meet Montana. All Rights Reserved